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Proteasome-Mediated Degradation of p21
via N-Terminal Ubiquitinylation
it has inhibited, so that the cell cycle can resume. How-
ever, p21 forms a stable interaction with cyclin/cdk com-
plexes and to be removed from them it needs to be
Joanna Bloom,1 Virginia Amador,1
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1New York University Cancer Institute and targeted to the proteasome, which in turn unfolds and
degrades p21, releasing cdks untouched and active.New York University School of Medicine
New York, New York 10016 Many questions remain as to the mechanism of p21
proteolysis by the 26S proteasome. Ubiquitinylated forms2 University of Texas
Southwestern Medical Center of both endogenous and exogenous p21 have been de-
tected in vivo (Cayrol and Ducommun, 1998; Fukuchi etDallas, Texas 75390
al., 2002; Maki and Howley, 1997; Maki et al., 1996;
Rousseau et al., 1999; Sheaff et al., 2000) but the signals
that induce proteasome-mediated degradation of p21Summary
are still not well understood. Although there is evidence
that during the progression through S phase the SCFSkp2We examined the mechanism responsible for the deg-
radation of p21, a negative regulator of the cell division ubiquitin ligase is involved in the degradation of p21
(Bornstein et al., 2003), p21 is a short-lived protein alsocycle. We found that p21 proteolysis requires func-
tional ubiquitin and Nedd8 systems. Ubiquitinylated at times when Skp2 is absent. In addition, whether ubi-
quitinylation is necessary for p21 degradation remainsforms of p21 and p21(K0), a p21 mutant missing all
lysines, are detected in vivo and in vitro, showing that unclear and it is actually believed that ubiquitinylation
is dispensable for the proteasomal degradation of p21the presence of lysines is dispensable for p21 ubiqui-
tinylation. Instead, the free amino group of the N-ter- (Sheaff et al., 2000). This conclusion was mostly based
on the fact that a mutant of p21 with all of its six lysinesminal methionine of p21 is a site for ubiquitinylation
in vivo. Although wild-type p21 is more abundantly mutated to arginines [p21(K0) mutant] is degraded at
the same rate as p21 in vivo. Moreover, it was shown thatubiquitinylated than p21(K0) mutant due to the pres-
ence of internal lysine residues, their rates of proteoly- p21 is able to bind the 7 subunit of the 20S proteasome,
suggesting that this interaction eliminates the need forsis are indistinguishable. These results demonstrate
that proteasomal degradation of p21 is regulated by polyubiquitinylation of p21 for recognition by the 26S
proteasome (Touitou et al., 2001). Taken together thesethe ubiquitin pathway and suggest that the site of the
ubiquitin chain is critical in making p21 a competent results have led to the commonly accepted belief that
the ubiquitinylation of p21 is unnecessary for its degra-substrate for the proteasome.
dation, which is therefore considered to be ubiquitin-
independent but proteasome-dependent.Introduction
We initiated studies to understand the mechanism by
which p21 is degraded without prior ubiquitinylation butThe cyclin-dependent kinase inhibitor p21, the product
of the Cip1 gene, is critical for regulation of the cell cycle found that the ubiquitin system is indeed required for
p21 proteolysis. Following is a description of our results.and DNA replication (Sherr and Roberts, 1999). The role
for p21 as an inhibitor of the cell cycle is based on its
ability to bind to cyclin/cdk complexes containing cdk2 Results
and block their activity. p21 appears to have a further
role at the G2 checkpoint by inhibiting the activity of Wild-Type p21 and p21(K0) Mutant Are
cdk1 and also positively regulates G1 progression by Ubiquitinylated and Degraded at Similar Rates
aiding in the assembly of cdk4 and cdk6 with D-type In Vitro, and Their Degradation Is Mediated
cyclins. Additionally, p21 can act as an inhibitor of DNA by a Functional Ubiquitin System
replication through its association with PCNA, a protein To investigate how the proteasome degrades p21, we
required for processive DNA synthesis. Binding of p21 developed an in vitro assay for the degradation of p21
to PCNA affects the ability of PCNA to associate with similar to what we use for a related protein, namely p27
other factors required for DNA replication. (Montagnoli et al., 1999). Wild-type p21 and p21(K0)
Levels of p21 protein are regulated during the cell mutant were in vitro translated using a rabbit reticulo-
cycle at the levels of transcription and protein degrada- cyte lysate (RRL) in the presence of 35S-methionine and
tion. Transcriptional control of p21 has been well charac- then incubated with an ATP regenerating system in the
terized, particularly in response to serum. In fact, al- absence or presence of purified 26S proteasomes. Since
though in quiescent cells, p21 is already expressed and endogenous proteasomes are present in RRL, we ex-
bound to cdks, a further increase in p21 is induced by pected to see some degradation in the absence of puri-
serum in early G1 via a serum-responsive element in its fied proteasomes. Indeed, we found that both wild-type
promoter to prevent premature activation of cdks and p21 and p21(K0) mutant were degraded over time in the
activation of DNA synthesis. Then later, for cells to enter absence of added 26S proteasomes (Figures 1A and
S phase, p21 needs to be removed from the cdks that 1B, lanes 1–5) but that the supplement of exogenous
26S proteasomes enhanced their degradation (Figures
1A and 1B, lanes 6–10). RRL contains not only protea-*Correspondence: michele.pagano@med.nyu.edu
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Figure 1. Wild-Type and p21(K0) Mutant Are Ubiquitinylated and Degraded In Vitro
(A–C) Inhibition of polyubiquitin chain formation induces p21 stabilization.
(A) Degradation of 35S wild-type p21 was carried out in the absence (lanes 1–5) or presence (lanes 6–15) of purified 26S proteasomes (26S)
and methylated ubiquitin (MeUb) (lanes 11–15) for the indicated times. Reaction products were run on SDS-PAGE followed by autoradiography.
(B) Degradation of 35S p21(K0) mutant was carried out in the absence (lanes 1–5) or presence (lanes 6–15) of purified 26S proteasomes (26S)
and MeUb (lanes 11–15) for the indicated times. Reaction products were run on SDS-PAGE followed by autoradiography.
(C) Quantification of the results shown in lanes 6–15 of (A) and (B).
(D–E) p21(K0) mutant is ubiquitinylated in vitro.
(D) Longer exposures of results shown in (A).
(E) Longer exposures of results shown in (B). The bracket on the left side of the images marks a ladder of bands 21,000 corresponding to
polyubiquitinylated p21.
somes but is also an established source of ubiquitinylat- wild-type p21 and p21(K0) mutant almost completely
disappeared, and bands corresponding to mono-, di-,ing enzymes (Hershko, 1988). We reasoned that if p21
is degraded by the proteasome in the absence of poly- and triubiquitinylated species of p21 appeared. The di-
and triubiquitinylated forms of p21 represent one ubiqui-ubiquitin chain formation, inhibition of polyubiquitin
chain formation should not affect the degradation of tin molecule present in the RRL capped by a methylated
ubiquitin or two endogenous ubiquitin molecules cap-in vitro translated p21. Thus, we included methylated
ubiquitin, which is chemically modified to block all of its ped by a methylated ubiquitin, respectively. The fact
that methylated ubiquitin changes the pattern of bandsfree amino groups and is therefore incapable of forming
polyubiquitin chains, to the in vitro reaction. Surpris- confirms that the higher molecular weight forms of p21
are indeed p21 polyubiquitinylated species. For reasonsingly, in the presence of methylated ubiquitin, the half-
lives of both wild-type p21 and p21(K0) mutant were not yet understood, the monoubiquitinylated band was
much less evident for p21(K0) mutant whereas bandssignificantly increased (Figures 1A and 1B, lanes 11–15,
and Figure 1C). This result suggests that the in vitro corresponding to the di- and triubiquitinylated species
were more apparent (compare lanes 11–15 in Figuresdegradation of p21 is dependent on polyubiquitin chain
formation, which is not in agreement with the notion that 1D and 1E).
Taken together, these results show that a functionalp21 degradation is ubiquitin-independent. Importantly,
longer exposures of films in Figure 1A revealed that ubiquitin system is necessary for the polyubiquitiny-
lation and efficient degradation of wild-type p21 andpolyubiquitinylated species of p21 accumulated over
time (Figure 1D). Unexpectedly, these higher molecular p21(K0) mutant in vitro.
weight forms were also visible with the p21(K0) mutant
(Figure 1E), showing the availability of lysines is not Free p21 Is Degraded In Vitro by the 26S
Proteasome in the Absence of Stablerequired for p21 ubiquitinylation and suggesting that
this mutant can be ubiquitinylated at the N terminus (see Binding to the Proteasome
It has been reported that purified recombinant p21 canbelow). When methylated ubiquitin was added to the in
vitro reactions, the high molecular weight forms of both be degraded in vitro by both 20S and 26S purified pro-
Ubiquitin-Dependent Degradation of p21
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Figure 2. Free p21, but Not Bound p21, Is Degraded by the Proteasome Without Ubiquitinylation
(A–B) In vitro ubiquitin-independent degradation of free p21 by proteasomes is inhibited by its binding to cyclin E/cdk2.
(A) Degradation of purified wild-type p21 was carried out in the presence of purified 26S proteasomes either alone (lanes 3–6) or in the
presence of methylated ubiquitin (MeUb) (lanes 7–10) or purified recombinant cyclin E/cdk2 complexes (lanes 11–14) at 37C for the indicated
intervals. In lane 1, the reaction was carried out in the absence of substrate and in lane 2, the reaction was carried out in the absence of
purified 26S proteasomes.
(B) Degradation of purified p21(K0) mutant was carried out in the presence of purified 26S proteasomes either alone (lanes 3–6) or in the
presence of MeUb (lanes 7–10) or purified recombinant cyclin E/cdk2 (lanes 11–14) at 37C for the indicated intervals. The reaction shown in
lane 1 was carried out in the absence of substrate and that in lane 2 was carried out in the absence of purified 26S proteasomes.
(C–D) Binding of p21 to the proteasome in not required for proteasomal degradation of p21. (C) Pulldown of wild-type p21 (lanes 2–5) or
p21(1–133) (lanes 6–9) using GST alone (lanes 2 and 6), GST-S5a (lanes 3 and 7), GST-6 (lanes 4 and 8) or GST-7 (lanes 5 and 9). Ten
percent input of wild-type p21 and p21(1–133) are shown in lanes 1 and 10, respectively.
(D) Degradation of purified p21(1–133) mutant was carried out in the presence of purified 26S proteasomes either alone (lanes 3–6) or in the
presence of purified cyclin E/cdk2 (lanes 7–10) at 37C for the indicated intervals. The reaction shown in lane 1 was carried out in the absence
of substrate and that in lane 2 was carried out in the absence of purified 26S proteasomes.
(E) The large majority p21 is complexed in vivo. A Sepharose-6 column was used to separate p21 and its complexes present in human diploid
fibroblasts untreated (upper images) or treated with the proteasome inhibitor ZLLL (lower images). The elution of purified bacterial p21 is
shown in the bottom image. The elution of calibration standards is indicated at the top. Fractions were analyzed by immunoblotting with
antibodies to p21 and to the indicated p21-interacting proteins.
teasomes (Liu et al., 2003). In light of the findings de- addition of purified proteasomes. The presence of cyclin
E/cdk2 blocked the degradation of recombinant p21scribed in the previous section, we reexamined these
results. Recombinant wild-type p21 and p21(K0) mutant by 26S proteasomes (Figures 2A and 2B, lanes 11–14).
Abrogation of p21 degradation when complexed towere incubated with purified 26S proteasomes in the
presence of an ATP regenerating system. Wild-type cyclin E/cdk2 was not due to cyclin E, another proteaso-
mal substrate, being degraded instead (Figures 2A andp21and p21(K0) mutant were rapidly degraded by 26S
proteasomes (Figures 2A and 2B, lanes 1–6). In this 2B, lanes 11–14). Based on this result, we proposed
that purified recombinant p21 is degraded by the 26Spurified system, we would not expect a dependency of
p21 degradation on ubiquitin and, in fact, the addition proteasome since it is natively unfolded and as such
can enter the proteasome pore by diffusion. When p21of methylated ubiquitin did not block the degradation
of wild-type p21 or p21(K0) mutant (Figures 2A and 2B, is bound to another protein or protein complex, the ac-
cess to the proteasome is inhibited and p21 cannot belanes 7–10). Since free p21 is an unstructured protein
(Kriwacki et al., 1996), we sought to determine if p21 in degraded unless it is polyubiquitinylated. This interpre-
tation is in agreement with the results presented in Fig-complex with other proteins is degraded by 26S protea-
somes. Wild-type p21 and p21(K0) mutant were preincu- ure 1, where at least 50% of p21 is bound to the rabbit
cdk2 present in the RRL (data not shown) and wherebated with purified cyclin E/cdk2 complexes prior to the
Cell
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the addition of methylated ubiquitin inhibited both p21 mulated (Figure 3A), showing that inhibition of polyubiq-
uitin chain formation does not allow for efficient degra-polyubiquitinylation and degradation. If our hypothesis
were correct, then free p21 would be degraded by the dation of p21. Since ZLLL reaches all treated cells, while
only a fraction of cells is efficiently transfected withproteasome independently of its ability to form a stable
complex with it. It has been reported that p21 binds the Ub(K0) mutant, it is not surprising that the effect of
Ub(K0) mutant on the accumulation of p21 was slightly7 subunit of the proteasome through its extreme C
terminus and it has been proposed that this domain is less pronounced than the effect of ZLLL treatment. We
also tested the effects of ZLLL and the Ub(K0) mutant onrequired for the ubiquitin-independent degradation of
p21 (Touitou et al., 2001). We tested whether a p21 exogenously expressed p21 by transfecting both wild-
type p21 and the p21(K0) mutant in NIH-3T3 fibroblasts.deleted at its C terminus was still degraded by the pro-
teasome in vitro. Purified recombinant p21 C-terminal Cell extracts were analyzed by immunoblotting with an
antibody that recognizes human exogenous p21 but notmutant missing the last 31 amino acids [p21(1–133) mu-
tant], which is incapable of binding the 7 subunit of murine endogenous p21. Similarly to previously pub-
lished results (Sheaff et al., 2000), levels of both wild-the proteasome (Figure 2C and Touitou et al., 2001),
was incubated with 26S proteasomes in the presence type p21 and p21(K0) mutant cotransfected with wild-
type ubiquitin increased in the presence of ZLLL asof an ATP regenerating system. Similarly to wild-type
p21, p21(1–133) mutant was rapidly degraded by puri- compared to the DMSO-treated control (Figure 3B), indi-
cating that both are proteasomal substrates. Impor-fied proteasomes (Figure 2D), showing that an interac-
tion with proteasomes is not a prerequisite for the de- tantly, in the presence of Ub(K0) mutant, both wild-type
p21 and p21(K0) mutant accumulated to levels similargradation of free p21. When p21(1–133) mutant was
preincubated with cyclin E/cdk2 complexes, its degra- to those with proteasome inhibition alone, showing that
formation of polyubiquitin chains is essential not onlydation by 26S proteasomes was blocked (Figure 2D)
similarly to the wild-type protein. for the degradation of wild-type p21 but also of the
p21(K0) mutant. Previously published data showed thatThus, we concluded that only free but not complexed
p21 is degraded in vitro by the proteasome in a ubiquitin- in the presence of Ub(K0) mutant, p21 did not accumu-
late (Sheaff et al., 2000) suggesting that ubiquitinylationindependent manner. Since a stable interaction between
p21 and the proteasome is not required for p21 degrada- is not required for the proteasomal degradation of p21.
We reasoned that due to the abundance of endogenoustion and since p21 is a natively disordered protein, the
in vitro degradation of p21 in a purified system does not ubiquitin, insufficient levels of Ub(K0) mutant may be
unable to induce the increase in p21 levels. To determineseem to be a regulated process but only relies on the
ability of free p21 to access the catalytic core of the if the effect of Ub(K0) mutant on p21 is dose-dependent,
we transfected NIH-3T3 cells with p21 plus increasingproteasome, an ability negated when p21 is complexed
with other proteins. amounts of the Ub(K0) mutant. We found that p21 accu-
mulation induced by the Ub(K0) mutant is indeed dose-
dependent (Figure 3C), suggesting that previously pub-In Vivo Degradation of p21 Is Dependent
lished experiments were performed in the presence ofon a Functional Ubiquitin System
insufficient Ub(K0) mutant.Since unbound p21 is degraded in vitro by the protea-
Next, we measured the half-lives of wild-type p21some in the absence of ubiquitinylation, we asked whether
and p21(K0) mutant to test whether the accumulationfree p21 exists in vivo. Extracts from normal human
induced by inhibition of polyubiquitinylation is due tofibroblasts were subjected to Sepharose-6 gel filtration
decreased degradation. Since p21 is not easily detect-chromatography. In contrast to purified bacterial p21,
able in the presence of wild-type ubiquitin (see Figurewhich has an apparent molecular weight compatible
3B, lanes 1 and 4), to be able to measure its half-life,with a monomeric form, cellular p21 is largely part of
we transfected higher amounts of p21 cDNAs in thehigher molecular weight complexes with the majority of
presence of wild-type ubiquitin than in the presence ofp21 migrating in fractions 26 and 27 corresponding to
the Ub(K0) mutant. This explains why the increase incomplexes between the sizes of 44 kDa and 158 kDa
p21 steady state levels in the presence of Ub(K0) mutant(Figure 2E). Importantly, this is not due to the rapid
(Figure 3D, lanes 1 and 5) is not as pronounced as thatdegradation of free p21 in a ubiquitin-independent man-
in Figure 3B. Yet, in the presence of Ub(K0) mutant thener, because when cells were treated with the protea-
half-lives of both wild-type p21 and p21(K0) mutant weresome inhibitor ZLLL, p21 was still found in the same
significantly increased (Figure 3D). Taken together,higher molecular weight fractions.
these results implicate polyubiquitinylation as being crit-Since the majority if not all cellular p21 is present in
ical for proteasomal degradation of p21.a bound form, we excluded the possibility that p21 might
access the proteasome just by diffusion and hypothe-
sized that its degradation is a regulated process. Based In Vivo Degradation of p21 Is Dependent
on a Functional Ubiquitin-Activating Enzymeon our in vitro results, we asked whether cellular p21
is degraded in a ubiquitin-dependent manner in vivo. and a Functional Nedd8-Activating Enzyme
To confirm that the ubiquitin pathway is necessary for293T cells were either treated with the proteasome inhib-
itor ZLLL or transfected with a mutant ubiquitin with the degradation of p21, we took advantage of the
tsBN75 cell line that is temperature-sensitive for theall of its lysines mutated to arginines [Ub(K0) mutant],
which, similarly to methylated ubiquitin used in the in ubiquitin-activating enzyme E1 (Nishimoto et al., 1980).
We first examined endogenous levels of p21 in tsBN75vitro experiments, cannot form polyubiquitin chains. In
the presence of Ub(K0) mutant, endogenous p21 accu- cells incubated at the permissive (34C) or nonpermis-
Ubiquitin-Dependent Degradation of p21
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Figure 3. p21 Degradation Requires a Functional Ubiquitin System
(A–C) p21 is stabilized by both inhibition of proteasome function and inhibition of polyubiquitin chain formation.
(A) 293T cells were untreated (lanes 1 and 3) or treated with ZLLL (lane 2). 293T cells shown in lane 3 were transfected with Ub(K0) mutant.
Protein extracts were analyzed by immunoblotting with the indicated antibodies.
(B) NIH-3T3 cells were transfected with wild-type p21 (lanes 1–3) or p21(K0) mutant (lanes 4–6) in combination with wild-type ubiquitin (lanes
1–2 and 4–5) or Ub(K0) mutant (lanes 3 and 6). Cells were untreated (lanes 1, 3, 4, and 6) or treated with ZLLL (lanes 2 and 5). Protein extracts
were analyzed by immunoblotting with the indicated antibodies.
(C) NIH-3T3 cells were transfected with wild-type p21 (lanes 1–4) or cyclin E (lanes 5–8) in combination with increasing amounts of an expression
vector encoding Ub(K0) mutant. Accumulation of p21 and cyclin E in the presence of Ub(K0) mutant was monitored by immunoblot analysis.
(D) NIH-3T3 cells were transfected with wild-type p21 (upper image) or p21(K0) mutant (lower image) in combination with wild-type ubiquitin
(lanes 1–4) or Ub(K0) mutant (lanes 5–8). Cells were incubated in the presence of cycloheximide (CHX) for the indicated times. Degradation
of wild-type p21 and p21(K0) mutant was monitored by immunoblotting.
sive (40C) temperature by immunoblot analysis. At the the increase in p21 at the nonpermissive temperature
is likely due to a stabilization of the protein and not duenonpermissive temperature, p21 protein accumulated
(Figure 4A) and was stabilized (Figure 4B); however, to increased synthesis. To determine if both wild-type
p21 and p21(K0) mutant are stabilized when APP-BP1because p21 is a transcriptional target of p53, which also
accumulated at the nonpermissive temperature (Figure is nonfunctional, we infected ts41 cells with retroviruses
encoding wild-type p21 or p21(K0) mutant. We found4A), we determined if the accumulation of p21 at the
nonpermissive temperature was synthesis-indepen- that both proteins accumulated at the nonpermissive
temperature (Figure 4E). These data show that p21 deg-dent. Therefore, tsBN75 cells were infected with retrovi-
ruses encoding wild-type p21 or p21(K0) mutant, which radation is downstream of the Nedd8 pathway and sug-
gest that p21 is a substrate of cullin-dependent ubiqui-are under the control of a promoter no longer sensitive
to transcriptional activation by p53 and incubated at the tin ligases.
permissive or nonpermissive temperature for different
times. We found that levels of exogenous wild-type p21 Lysines Are Not Required for p21
Ubiquitinylation In Vivoand p21(K0) mutant increased at the nonpermissive tem-
perature (Figure 4C). These data show that inactivation The fact that a functional ubiquitin system is essential
for the degradation of p21 and that p21(K0) mutant canof the E1 ubiquitin-activating enzyme and consequently
of the ubiquitin pathway results in the stabilization of p21 be ubiquitinylated in vitro led us to examine the ubiquiti-
nylation status of p21(K0) mutant in vivo. First, we ex-protein regardless of the availability of internal lysines.
Next, we used the ts41 cell line that is temperature- pressed increasing amount of wild-type p21 or p21(K0)
mutant in 293T cells in the absence or presence of thesensitive for the Nedd8-activating enzyme APP-BP1
(Handeli and Weintraub, 1992). At the nonpermissive proteasome inhibitor ZLLL or in the presence of Ub(K0)
mutant and analyzed p21 by immunoblotting. Whentemperature (40C), Nedd8 is no longer conjugated to
cullins rendering them less active and all substrates of higher levels of wild-type p21 or p21(K0) mutant cDNA
were used for transfection, we were able to visualizecullin-based ligases would be expected to accumulate.
We found that after incubation at the nonpermissive high molecular weight species of p21 (Figure 5A, lanes
4 and 16) that correspond to ubiquitinylated forms (seetemperature, there was an increase in endogenous p21
levels, which correlated with Cul1 deneddylation (Figure below, Figure 5B). These bands and others of very high
molecular weight became more evident in the presence4D). Since p53 is not a substrate of cullin-based ubiquitin
ligases (Querido et al., 2001), it did not accumulate at of ZLLL (Figure 5A, compare lanes 4 and 8 and lanes
16 and 20), indicating that when proteasome function isthe nonpermissive temperature (Figure 4D); therefore,
Cell
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Figure 4. p21 Degradation Requires a Functional Ubiquitin-Activating Enzyme and Nedd8-Activating Enzyme
(A–C) p21 protein is stabilized when the ubiquitin-activating enzyme is not functional.
(A) tsBN75 cells were incubated at the permissive temperature (34C; lanes 1–3) or nonpermissive temperature (40C; lanes 4–6) for the
indicated intervals. Protein extracts were analyzed by immunoblotting with the antibodies to the indicated proteins.
(B) tsBN75 cells were incubated at the permissive temperature (34C; lanes 1–4) or nonpermissive temperature (40C; lanes 5–8) for 18 hr.
Cells were then incubated in the presence of cycloheximide (CHX) for the indicated times. Protein extracts were analyzed by immunoblotting
with the antibodies to the indicated proteins. The middle image represents a short exposure time and the upper image represents a long
exposure time.
(C) tsBN75 cells infected with retroviruses expressing wild-type p21 (lanes 1–6) or p21(K0) mutant (lanes 8–13) were incubated at the permissive
temperature (34C; lanes 1–3 and 8–10) or nonpermissive temperature (40C; lanes 4–6 and 11–13) for the indicated intervals. Lanes 7 and 14
show extracts from tsBN75 cells infected with an empty retrovirus and incubated at the nonpermissive temperature for 24 hr. Protein extracts
were analyzed by immunoblotting with the antibodies to the indicated proteins.
(D–E) p21 protein accumulates when the Nedd8-activating enzyme is not functional.
(D) ts41 cells were incubated at the permissive temperature (34C; lanes 1–4) or nonpermissive temperature (40C; lanes 5–8) for the indicated
intervals. Protein extracts were analyzed by immunoblotting with the antibodies to the indicated proteins. A long exposure of Cul1 reveals
that the Nedd8-conjugated form of Cul1 disappears at the nonpermissive temperature.
(E) ts41 cells infected with retroviruses expressing wild-type p21 (lanes 1–6) or p21(K0) mutant (lanes 8–13) were incubated at the permissive
temperature (34C; lanes 1–3 and 8–10) or nonpermissive temperature (40C; lanes 4–6 and 11–13) for the indicated intervals. Lanes 7 and 14
show extracts from ts41 cells infected with an empty retrovirus and incubated at the nonpermissive temperature for 24 hr. Protein extracts
were analyzed by immunoblotting with the antibodies to the indicated proteins.
abrogated, ubiquitinylated species of p21 accumulate. purified ubiquitinylated proteins with an antibody to p21
(Figure 5B, lanes 1–6) or to HA (Figure 5B, lanes 7–9)When p21 was cotransfected with Ub(K0) mutant, the
very high molecular weight forms disappeared and lower showed multiple higher molecular weight forms corre-
sponding to ubiquitinylated wild-type p21 and p21(K0)molecular weight ubiquitinylated species were instead
evident (Figure 5A, lanes 10–12 and 22–24). This indi- mutant. Since in these transfections we used a His-
myc-tagged ubiquitin, the ubiquitin chains bound to p21cates that the Ub(K0) mutant competes with endoge-
nous ubiquitin to terminate chains generating short p21- contain different proportions of both exogenous ubiqui-
tin (10.5 kDa) and endogenous ubiquitin (7.8 kDa).ubiquitin conjugates, which accumulate since they are
not efficiently degraded by the proteasome. In addition, This explains why ubiquitinated species appear in some
cases as a cluster of bands rather than a ladder of bands.this proves that p21 is modified by a canonical branched
chain, not by a linear ubiquitin chain. To verify that slow To further prove that p21 is indeed ubiquitinylated in
vivo, extracts from cells transfected with HA-tagged p21migrating bands are indeed ubiquitinylated species, ly-
sates from NIH-3T3 cells (Figure 5B, lanes 1–3) and 293T were immunoprecipitated with an antibody to the HA tag
under denaturing conditions to dissociate any proteinscells (Figure 5B, lanes 4–9) were subjected to a nickel-
agarose pulldown to purify ubiquitinylated proteins interacting with p21 that may also be ubiquitinylated.
Immunoblot analysis of denatured immunoprecipitatesthrough the histidine (His) tag on ubiquitin, which was
cotransfected with HA-tagged p21. Immunoblotting of with an antibody to ubiquitin specific for long polyubiqui-
Ubiquitin-Dependent Degradation of p21
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Figure 5. Wild-Type p21 and p21(K0) Mutant Are Ubiquitinylated In Vivo
(A) 293T cells were either untransfected (lanes 1, 5, 9, 13, 17, and 21) or transfected with increasing amounts of wild-type p21 (lanes 2–4, 6–8,
and 10–12) or p21(K0) mutant (lanes 14–16, 18–20, and 22–24). Lanes 5–8 and 17–20 show extracts from cells treated with ZLLL, and lanes
9–12 and 21–24 contain extract from cells transfected with Ub(K0) mutant. Protein extracts were analyzed by immunoblotting with an antibody
to p21. The lower image represents a short exposure time and the upper image represents a long exposure time. The blot in the upper right
image was exposed longer than the blot in upper left image. The bracket on the left side of the images marks a ladder of bands 21,000
corresponding to ubiquitinylated p21.
(B) NIH-3T3 cells (lanes 1–3) or 293T cells (lanes 4–12) were transfected with His-tagged ubiquitin in the presence of an empty vector (lanes
1, 4, 7, and 10), wild-type p21 tagged at the C terminus with HA (lanes 2, 5, 8, and 11) or p21(K0) mutant tagged at the C terminus with HA
(lanes 3, 6, 9, and 12). Cell extracts were subjected to nickel agarose purification (lanes 1–9) or immunoprecipitated with an anti-HA antibody
(lanes 10–12). Where indicated, an amount of extract corresponding to twice the amount used for the wild-type p21 expressing extract was
used [indicated as (2)]. Precipitates were analyzed by immunoblotting with an antibody to p21 (lanes 1–6), an antibody against the HA tag
(lanes 7–9) or an antibody specific for long polyubiquitin chains (lanes 10–12). The bracket on the left side of the images marks a ladder of
bands 21,000 corresponding to ubiquitinylated p21.
tin chains (Montagnoli et al., 1999) confirmed that both difference was confirmed by nickel-agarose pulldowns
followed by immunoblotting (compare lanes 2 and 3,wild-type p21 and p21(K0) mutant are in fact ubiquitiny-
lated in vivo (Figure 5B, lanes 10–12). and lanes 11 and 12 in Figure 5B) prompting us to use
in the pulldowns from 293T cells twice the amount ofIn direct immunoblots, we noticed that p21(K0) mutant
appeared quantitatively less ubiquitinylated than wild- lysate from p21(K0) mutant expressing cells than from
p21 wild-type expressing cells, to better compare thetype p21 (the blot shown in the right image of Figure 5A
was exposed longer than that in the left image). This ubiquitinylation of the two p21 forms (Figure 5B, lanes
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5–6 and 8–9). Thus, we concluded that despite having The His-tagged ubiquitin we used also contains a myc
tag and as a result has an apparent molecular mass ofa similar half-life, wild-type p21 is ubiquitinylated more
than p21(K0) mutant. 10,500 Da; therefore, two His-ubiquitin moieties show
the same migration in SDS-PAGE as p21. This explains
why the pattern of bands of the ubiquitinylated unclea-p21 Is Ubiquitinylated at the N Terminus In Vivo
ved p21 and the polyubiquitinylated cleaved HA tag isSince p21 ubiquitinylation did not require the presence
similar. For example, the triubiquitinylated form of theof lysine residues, we sought to examine the possibility
HA tag is almost identical in size to the monoubiquitiny-that the N terminus of wild-type p21 and p21(K0) mutant
lated form of uncleaved p21. Thus, the close electropho-is the target for ubiquitinylation in vivo. We generated
retic mobility of ubiquitinylated p21 and ubiquitinylatedconstructs of wild-type p21 and p21(K0) mutant that
HA tag explains the overall similarity between lanes withafter the first methionine contain an HA tag (which does
and without factor Xa (with the exception of the keynot contain any lysine: Tyr-Pro-Tyr-Asp-Val-Pro-Asp-
presence of monoubiquitinylated HA-tag in cleavedTyr-Ala) followed by a factor Xa protease cleavage site
samples). To further verify this explanation, we per-(Ile-Glu-Gly-Arg); these constructs were cotransfected
formed an identical experiment using a truncated p21in 293T cells together with His-tagged ubiquitin. Twenty-
(1–133) mutant containing an HA tag followed by a factorfour hours after transfections cells were collected and
Xa cleavage site. This mutant is missing 31 amino acidseach cell extract was divided in two aliquots, one of
at the C terminus and therefore has a faster electropho-which was treated with factor Xa protease. Essentially,
retic mobility. The result of this experiment (Figure 6C)all of p21 had its N-terminal HA tag removed in the
demonstrates that the ubiquitinylated forms of the HApresence of factor Xa as shown by the increase in gel
tag derived from both wild-type p21 and p21(1–133)migration (Figure 6A compare lanes 3 and 5 to lanes 4
mutant are very similar (see asterisks in lane 3 of Figureand 6). We then performed a nickel agarose pulldown
6C and in lane 4 of Figure 6B) and they both resemblewith both the cleaved and uncleaved forms of wild-type
the pattern of bands corresponding to ubiquitinylatedp21 and p21(K0) mutant. If p21 is not ubiquitinylated
wild-type p21 (compare lane 3 to lane 2 in Figure 6C).at the N terminus, when factor Xa-treated extracts are
Instead, the bands corresponding to ubiquitinylatedpulled down with nickel agarose and immunoblotted
wild-type p21 and p21(1–133) mutant differ in size, dem-with an antibody to HA, we should not be able to detect
onstrating that the cleaved samples do not contain anyubiquitinylated proteins since the HA tag has been cut
residual uncut ubiquitinylated p21 species but ratheraway. If instead p21 is indeed ubiquitinylated at the
represent ubiquitinylated species of the HA tag.N terminus, we should observe ubiquitinylated forms
These experiments show that both wild-type p21 andwhether the extract is untreated or is treated with factor
p21(K0) mutant are ubiquitinylated on the N-terminalXa since the N-terminal HA tag, although separated from
methionine in vivo.p21, is still covalently bound to ubiquitin chains. In addi-
tion, for the extracts that were pretreated with factor Xa
protease, we would expect to see a lower molecular Addition of an N-Terminal Tag Stabilizes p21 In
Vivo but Does Not Block Its Ubiquitinylationband corresponding to the monoubiquitinylated form of
the N-terminal HA tag, which would be absent for the As indirect evidence that certain proteins are ubiquitiny-
lated at the N terminus, it has been shown that they areuncleaved p21. After nickel agarose purification, we did
observe ubiquitinylated species of both uncleaved p21 stabilized by the addition of seventy-eight amino acids
(a 6-myc tag represented by the following sequenceand the cleaved N-terminal HA tag (Figure 6B). In addi-
tion, only after treatment with factor Xa, we observed repeated 6-fold: Met-Glu-Gln-Lys-Leu-Ileu-Ser-Glu-Glu-
Asp-Leu-Asn-Glu) fused to their N-terminal methioninethe appearance of a monoubiquitinylated form of the
N-terminal HA tag (indicated in Figure 6B as HA-Ub1), (Aviel et al., 2000; Breitschopf et al., 1998; Reinstein et
al., 2000). This result was explained as the ability of thewhich had the same mobility as His-myc-tagged ubiqui-
tin and was also recognized by an antibody to ubiquitin 6-myc tag to block the recognition site for ubiquitin
ligases or ubiquitin or both. We generated constructs(data not shown). Significantly, taking in account the
monoubiquitinylated form of the HA tag, the amount of of wild-type and p21(K0) mutant in which a 6-myc tag
was fused to the N-terminal methionine. When ex-ubiquitinylated HA tag derived from p21(K0) (lane 6) is
comparable to the amount of ubiquitinylated p21(K0) pressed in cells, these tagged versions of wild-type p21
and p21(K0) mutant were still able to inhibit cell prolifera-(lane 5). In contrast, wild-type p21 can be ubiquitinylated
on the N-terminal methionine as well as on multiple tion and bind to cdk2, cdk4, cyclin A, cyclin B, and
cyclin D1 (data not shown). Untagged or 6-myc taggedlysine residues, accounting for the lower levels of ubiqui-
tinylation of the HA-tag derived from wild-type p21 (com- versions of wild-type p21 and p21(K0) mutant were
transfected into NIH-3T3 cells and their half-lives werepare lanes 3 and 4). As indicated, to better compare the
ubiquitinylation of the two p21 forms before cleavage measured. We found that while untagged wild-type p21
and p21(K0) mutant were degraded over time, 6-myc(lanes 3 and 5) we used twice the amount of lysate from
p21(K0) mutant expressing cells than from p21 wild- tagged versions were more stable (Figure 7A) and were
still not degraded after eight hours (data not shown).type expressing cells. Because of this, after cleavage
(lanes 4 and 6) a difference between wild-type and mu- However, when we compared the ubiquitinylation status
of untagged and 6-myc tagged wild-type p21 andtant is evident since the total amount of N-terminal
ubiquitinylation in these two forms is likely to be the p21(K0) mutant, we found that the 6-myc tagged ver-
sions were ubiquitinylated more than the untagged ver-same but we are using twice as much extract for the
p21(K0) mutant. sions (Figure 7B). This is not surprising since the tag
Ubiquitin-Dependent Degradation of p21
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Figure 6. p21 Is Ubiquitinylated on the N Terminus In Vivo
(A) 293T cells were transfected with His-tagged ubiquitin plus empty vector (lanes 1 and 2), wild-type p21 with an N-terminal HA tag followed
by a factor Xa cleavage site (HA-X-p21; lanes 3 and 4) or p21(K0) mutant with an N-terminal HA tag followed by a factor Xa cleavage site
(HA-X-p21(K0); lanes 5 and 6). Extracts from transfected cells were left untreated (lanes 1, 3, and 5) or were treated with factor Xa protease
(lanes 2, 4 and 6). Protein extracts were analyzed by immunoblotting with an antibody to p21.
(B) Cell extracts shown in (A) were subjected to nickel agarose purification and precipitates were analyzed by immunoblotting with an antibody
against the HA tag. The bracket on the left side of the images marks a ladder of bands 21,000 corresponding to ubiquitinylated p21 (lanes
3 and 5) or polyubiquitinylated HA (lanes 4 and 6). The arrow on the left side marks the monoubiquitinylated form of the HA tag (lanes 4 and
6). Asterisks indicate the major polyubiquitinylated forms of the HA tag.
(C) 293T cells were transfected with His-tagged ubiquitin plus HA-X-p21(1–133) (lanes 1 and 3) or HA-X-p21 (lanes 2). Extracts from transfected
cells were left untreated (lanes 1 and 2) or were treated with factor Xa protease (lane 3). Cell extracts were subjected to nickel agarose
purification and precipitates were analyzed by immunoblotting with an antibody against the HA tag. The bracket on the left side of the images
marks a ladder of bands 21,000 corresponding to ubiquitinylated p21 (lanes 1 and 2) or polyubiquitinylated HA (lane 3). Asterisks indicate
the major polyubiquitinylated forms of the HA tag. The arrow on the left side marks the monoubiquitinylated form of the HA tag (lane 3).
contains six lysines and could at least theoretically be Discussion
ubiquitinylated at the N terminus. What is surprising is
that amply ubiquitinylated p21 is more stable. It is very Can a Protein Be Degraded by the Proteasome
in the Absence of Its Ubiquitinylation?unlikely that the 6-myc tag causes a steric hindrance
that interferes with unfolding by and/or translocation There is only one clear example of a protein that is
targeted for degradation by the 26S proteasome withoutinto the proteasome independent of the presence of the
ubiquitin chain, since the same tag does not change the prior ubiquitinylation. The enzyme ornithine decarboxyl-
ase (Odc) is a short-lived protein whose degradation bystability of other proteins (e.g., Emi1 in Guardavaccaro
et al., 2003). In addition, ubiquitinylated p21 bound to the 26S proteasome is ATP-dependent but ubiquitin-
independent. Yet, the proteolysis of Odc is a regulatedthe proteasome but not proteolyzed could get in the way
of other proteins delaying their degradation. Instead, we process that depends on the binding of Odc to a specific
cofactor, antizyme. Once bound to antizyme, Odc isfound that other proteins analyzed (both endogenous
and exogenous) are still unstable in cells transfected recognized and degraded by the 26S proteasome with
the release of antizyme (Li and Coffino, 1992). Therewith 6-myc tagged p21(K0) mutant (data not shown).
Thus, p21 conjugated to polyubiquitin chains on the are two reports in the literature proposing additional
substrates for ubiquitin-independent degradation, namely6-myc tagged is intrinsically incompetent to serve as
an efficient substrate of the proteasome suggesting that p21 (Sheaff et al., 2000) and c-Jun (Jariel-Encontre et
al., 1995). However, unlike for Odc, a clear targetingthe position of the chain plays an important role in the
rate of proteasomal degradation. mechanism to the proteasome has not been described
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Figure 7. Modification of the N Terminus of
p21 Blocks Its Degradation, but Not Its Ubi-
quitinylation In Vivo
(A) NIH-3T3 cells were transfected with wild-
type p21 (lanes 1–4), 6-myc-tagged wild-
type p21 (lanes 5–8), p21(K0) mutant (lanes
9–12), or 6-myc-tagged p21(K0) mutant
(lanes 13–16). Cells were incubated in the
presence of cycloheximide (CHX) for the indi-
cated times. Protein extracts were analyzed
by immunoblotting with the antibodies to the
indicated proteins.
(B) 293T cells were transfected with His-
tagged ubiquitin in the presence of an empty
vector (lane 1), wild-type p21 (lane 2), 6-
myc-tagged wild-type p21 (lane 3), p21(K0)
mutant (lane 4), or 6-myc-tagged p21(K0)
mutant (lane 5). Cell extracts were subjected
to nickel agarose purification and precipi-
tates were analyzed by immunoblotting with
an antibody to p21. The bracket on the left
side of the images marks a ladder of
bands 21,000 corresponding to ubiquitiny-
lated p21.
for either. It has been shown that p21 binds the 7 that regulation of p21 degradation both in vitro (Figure
1) and in vivo (Figures 3 and 4) is dependent on thesubunit of the proteasome (Touitou et al., 2001) and
suggested that this physical interaction might target p21 ubiquitin system. In addition, a functional Nedd8 conju-
gation system is required for p21 degradation in vivoto the proteasome for degradation. However, although
p21 can bind to 7, it has not been possible to detect (Figure 4).
an interaction between p21 and 7 integrated in the
proteasome, both in the absence and in the presence Are Lysines Necessary for Ubiquitinylation? And
How Many Ubiquitin Chains Are Necessary Forof proteasome inhibitors, whereas in the same experi-
ments known proteasomal interactors such as Cul1 and an Efficient Recognition and Degradation
by the Proteasome?Roc1 are readily detected (Touitou et al., 2001 and J.B.
and M.P., unpublished data). More importantly, from a Both in vitro and in vivo p21 can be targeted for degrada-
tion through the addition of ubiquitin to a nontraditional,steric point of view it is unclear how the binding with 7
would facilitate the access of p21 to the 26S proteasome nonlysine target residue (Figures 1, 5, 6, and 7). MyoD,
the Epstein-Barr virus latent membrane protein 1 and thesince 7 is distal from the entry to the proteasomal
channel. Indeed we show herein that only free p21 and E7 human papillomavirus oncoprotein can be degraded
in a ubiquitin-dependent and proteasome-dependentnot p21 in complex with additional proteins can be de-
graded by purified 26S proteasomes (Figures 2A and manner in the absence of lysine residues (Aviel et al.,
2000; Breitschopf et al., 1998; Reinstein et al., 2000). It2B) and that p21 lacking the binding to 7 is also readily
degraded by purified proteasomes when in its free form has been suggested that these proteins have the ubiqui-
tin chain conjugated to the N-terminal methionine resi-(Figures 2C and 2D). Accordingly, a p21(1–82) mutant
has an in vivo half-life identical to the wild-type p21 due; however, evidence for this type of modification has
thus far been indirect. Here, we provided direct proofprotein (Rousseau et al., 1999), confirming that binding
to 7 is not necessary for p21 proteolysis in vivo. p21 that both wild-type p21 and the p21(K0) mutant are ubiq-
uitinylated at the N terminus in vivo.is a critical protein for regulating the cell cycle and DNA
replication, and many of its functions are temporally We found that both in vitro and in vivo, wild-type p21
is more ubiquitinylated than p21(K0) mutant (Figures 1D,and probably spatially regulated. As a result, stringent
regulation of protein stability plays a role in controlling 1E, and 5B). Yet, the rate of their degradation is very
similar (Figures 1A, 1B, 3D, and 7A) suggesting thatp21 functions. Indiscriminate degradation of p21 due to
simple diffusion within proteasomes would be contrary lysine-dependent ubiquitinylation does not increase the
efficiency of the proteasome in degrading p21. More-to the necessity for rapidly regulating protein levels
through proteolysis. p21 is mostly found in complexes over, the addition of a 6-myc tag to the N terminus of
p21 stabilizes the protein in vivo (Figure 7A) although it(Figure 2E) and, based on our results, is not expected to
be degraded by proteasomes in a ubiquitin-independent does not inhibit, but actually increases, its ubiquitinyla-
tion. This result suggests that ubiquitinylation on themanner. Indeed, the results presented here demonstrate
Ubiquitin-Dependent Degradation of p21
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In Vivo Ubiquitinylation and Factor Xa CleavageN terminus is sufficient for degradation and that the
293T and NIH-3T3 cells were cotransfected with His-myc-taggedN-terminal site for ubiquitinylation is a physiologically
ubiquitin and either wild-type p21 or p21(K0) mutant tagged at therelevant site to make p21 a competent substrate for
C terminus with HA. Transfected cells were treated with 10 M ZLLL
proteasomal degradation. Recent work has shown that for 5 hr and extracts were prepared in lysis buffer including 100 M
the yeast cdk inhibitor, Sic1, can be ubiquitinylated on NEM and 20 M ubiquitin aldehyde. Lysates (0.5 ml volume) were
denatured by boiling for 10 min in the presence of 1% SDS. Lysatesmultiple lysine residues, but only ubiquitinylation on a
were then incubated with 100 l of 10% Triton X-100 and 400 l ofspecific single lysine residue can efficiently promote its
lysis buffer on ice for 30 min prior to nickel agarose purification ordegradation by proteasomes (Petroski and Deshaies,
immunoprecipitation. For Factor Xa cleavage, prior to nickel agarose2003). Our results are in agreement with this finding in
purification, extracts were treated with 1 g factor Xa protease for
that just one ubiquitin chain ligated to p21 efficiently 16 hr at 25C.
targets this protein for degradation. However, a ly-
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